The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.
From McMaster University, Hamilton, Ontario, Canada; Robert Wood Johnson Medical School, Piscataway, New Jersey; Université de Montréal, Montreal, Quebec, Canada; the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland; Harvard Medical School, Boston, Massachusetts; the University of Texas, Austin, Texas; the Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; and Memorial Sloan‐Kettering Cancer Center, New York, New York.